Interaction between glucose and lipid metabolism: More than diabetic dyslipidemia, Diabetes and Metabolism Journal (2015) Effects of semaglutide on cardiovascular risk factors and eating behaviors in Type 2 diabetes, Acta Diabetologica (2022) Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analysis, Diabetes, Obesity, and Metabolism (2023) Semaglutide and cardiovascular outcomes in patient with Type 2 diabetes, New England Journal of Medicine (2016) The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE-/- and LDLr-/- mice a mechanism that includes inflammatory pathways, JACC Basic to Translational Science (2018) Ozempic drug label, NIH DailyMed (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
This process supports enhanced fat metabolism, energy levels, and cellular repair, particularly within muscle and fat tissue
Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after GLP-1 initiation, researchers reported
10.1016/j.molmed.2024.10.010 Trends Mol
BioPharma Dive (2019)
